A cross-trial comparison of single-agent ibrutinib.

Tedeschi, A; Greil, R; Demirkan, F; Robak, T; Moreno, C; Barr, PM; Anz, B; Simpson, D; Gaidano, G; Bairey, O; Stevens, D; Gill, D; Flinn, IW; Kipps, TJ; Burger, JA; Lin, J; Webb, T; Fedorov, V; Styles, L; Gribben, JG.

Haematologica. 2020; 105(4):e164-e168.

https://pubmed.ncbi.nlm.nih.gov/31413095/